Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC

BACKGROUND: Renal cell carcinoma (RCC) is notorious for its resistance towards chemotherapy and radiation therapy in general. Combination therapy is often helpful in alleviating the resistance mechanisms by targeting multiple signaling pathways but is usually more toxic than monotherapy. Co-encapsul...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Krishnendu, Madamsetty, Vijay Sagar, Dutta, Shamit Kumar, Mukhopadhyay, Debabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636461/
https://www.ncbi.nlm.nih.gov/pubmed/31371950
http://dx.doi.org/10.2147/IJN.S204221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636461/
https://www.ncbi.nlm.nih.gov/pubmed/31371950
http://dx.doi.org/10.2147/IJN.S204221

Ejemplares similares